ICP DAS-BMP at WHX Dubai 2026: Highlighting Cutting-Edge TPU Innovations
At the upcoming WHX Dubai 2026, formerly known as Arab Health, ICP DAS-BMP, a Taiwanese leader in biomedical polymers, is set to unveil groundbreaking innovations in thermoplastic polyurethane (TPU) that cater specifically to the medical device industry. Scheduled to take place from February 9 to 12 at the Dubai Exhibition Centre, this event will feature ICP DAS-BMP's latest advances designed to meet the critical needs of healthcare providers and patients alike.
Located at Booth S7C117, ICP DAS-BMP will present two standout TPU product lines: the Low-Migration Series and the Low-Friction Series. These new materials are developed to enhance medical devices' functionality and safety through superior performance under various conditions.
Low-Migration Arothane™ ARP-B20 TPU
This innovative TPU offers ISO 10993 compliance, ensuring its safety for short-term implantation (up to 90 days). The Low-Migration Arothane™ ARP-B20 is specifically engineered to reduce additive migration during the manufacturing process. This characteristic is crucial for maintaining the integrity of medical devices, including catheters, by helping to retain their smooth surfaces throughout their shelf life. Additionally, the material allows for multiple color choices, enabling manufacturers to create customized designs tailored to clinical requirements and patient preferences.
Low-Friction Series
Designed to meet the needs of applications requiring smooth insertion, such as nasogastric tubes, the Low-Friction Series features an inherently slippery surface that negates the need for additional coatings or post-processing. Produced entirely from TPU, this series also boasts the absence of harmful substances like PFAS or plasticizers, ensuring long-term stability and optimal performance without the risk of surface exudation or additive migration. These properties make it an ideal choice for devices that demand precision and safety during storage and usage.
In addition to these innovative series, ICP DAS-BMP will exhibit a wide-ranging portfolio of TPU solutions for various medical applications. Their offerings include the ARP, ALP, and ALC series, which are suitable for devices classified as having Limited (less than 24 hours), Prolonged (24 hours to 30 days), and Long-term (over 30 days) contact durations, respectively, as per ISO 10993-1 standards. For radiopaque applications—essential for visibility during procedures—the ARP-B20 and ALC-B40 (qualified for 90-day implantation) will provide enhanced visibility, while the ARP-W/WG series offers further options with a tungsten content between 40-60% for invasive or implantable devices.
Furthermore, the Engineering Arothane™ EARP series stands out for its clarity and mechanical strength, making it suitable for orthodontic components, Luer-Lock connectors, and other precision medical devices. Together, these materials epitomize ICP DAS-BMP's commitment to developing safe, reliable, and versatile TPU solutions that empower medical device manufacturers to meet the ever-evolving needs of the healthcare industry.
About ICP DAS-BMP
Established in Taiwan, ICP DAS-BMP has established itself as a leading manufacturer and supplier of medical-grade TPU. With ISO 13485 certification and over thirty years of expertise in industrial automation from its parent company, ICP DAS, the firm leverages smart factory practices to enhance product quality and expedite delivery times. Their commitment to exceptional after-sales support and flexibility, even with small order quantities, ensures customer satisfaction and fosters long-term partnerships across the medical device industry.
For more details on their products and innovations, we invite interested parties to visit ICP DAS-BMP's official website at
https://bmp.icpdas.com.